Cargando…

Associations among systemic blood pressure, microalbuminuria and albuminuria in dogs affected with pituitary- and adrenal-dependent hyperadrenocorticism

BACKGROUND: Hypertension and proteinuria are medical complications associated with the multisystemic effects of long-term hypercortisolism in dogs with hyperadrenocorticism (HAC). METHODS: This study investigated the relationships among adrenocorticotropic hormone (ACTH)-stimulation test results, sy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lien, Yu-Hsin, Hsiang, Tsai-Yuan, Huang, Hui-Pi
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994942/ https://www.ncbi.nlm.nih.gov/pubmed/21070672 http://dx.doi.org/10.1186/1751-0147-52-61

Ejemplares similares

Association of Renal Resistive Index, Renal Pulsatility Index, Systemic Hypertension, and Albuminuria with Survival in Dogs with Pituitary-Dependent Hyperadrenocorticism
por: Chen, Hung-Yin, et al.
Publicado: (2016)

Serum Cortisol Concentrations in Dogs with Pituitary‐Dependent Hyperadrenocorticism and Atypical Hyperadrenocorticism
por: Frank, L.A., et al.
Publicado: (2014)

Changes in systolic blood pressure in dogs with pituitary dependent hyperadrenocorticism during the first year of trilostane treatment
por: García San José, Paula, et al.
Publicado: (2020)

Decrease of nitric oxide and increase in diastolic blood pressure are two events that affect renal function in dogs with pituitary dependent hyperadrenocorticism
por: Vidal, Patricia N., et al.
Publicado: (2018)

Laboratory assessment of trilostane treatment in dogs with pituitary‐dependent hyperadrenocorticism
por: Arenas Bermejo, Carolina, et al.
Publicado: (2020)

Serum Adipokine Concentrations in Dogs with Naturally Occurring Pituitary‐Dependent Hyperadrenocorticism
por: Cho, K.‐D., et al.
Publicado: (2013)

Effect of Trilostane and Mitotane on Aldosterone Secretory Reserve in Dogs with Pituitary‐Dependent Hyperadrenocorticism
por: Reid, L.E., et al.
Publicado: (2014)

Effect of Trilostane on Hormone and Serum Electrolyte Concentrations in Dogs with Pituitary‐Dependent Hyperadrenocorticism
por: Griebsch, C., et al.
Publicado: (2013)

Relationship of serum leptin concentration with pituitary‐dependent hyperadrenocorticism and cholestatic disease in dogs
por: Lee, S., et al.
Publicado: (2019)

Utility of a corticotropin‐releasing hormone test to differentiate pituitary‐dependent hyperadrenocorticism from cortisol‐producing adrenal tumors in dogs
por: Tanaka, Sachiyo, et al.
Publicado: (2021)

Carbenoxolone Disodium Treatment for Canine Pituitary-Dependent Hyperadrenocorticism
por: Teshima, Takahiro, et al.
Publicado: (2016)

Assessment of left ventricular function by two-dimensional speckle-tracking echocardiography in small breed dogs with hyperadrenocorticism
por: Chen, Hung-Yin, et al.
Publicado: (2014)

The effect of 1 year of trilostane treatment on peripheral lymphocyte subsets in dogs with pituitary-dependent hyperadrenocorticism
por: ODA, Hitomi, et al.
Publicado: (2016)

Skin fragility in a cat presenting with pituitary-dependent hyperadrenocorticism
por: Hardy, Lorna, et al.
Publicado: (2023)

Treatment of canine generalized demodicosis associated with hyperadrenocorticism with spot-on moxidectin and imidacloprid
por: Huang, Hui-Pi, et al.
Publicado: (2013)

Clinical Relationship between Cholestatic Disease and Pituitary‐Dependent Hyperadrenocorticism in Dogs: A Retrospective Case Series
por: Kim, K.‐h., et al.
Publicado: (2017)

Three Cases of Transtracheal Catheter Oxygenation for Postoperative Dyspnoea with Pituitary-Dependent Hyperadrenocorticism in Dogs Treated by Surgery
por: Tanaka, Sachiyo, et al.
Publicado: (2022)

Pituitary-dependent hyperadrenocorticism and generalised toxoplasmosis in a cat with neurological signs
por: Spada, Eva, et al.
Publicado: (2010)

The interpretive contribution of the baseline serum cortisol concentration of the ACTH stimulation test in the diagnosis of pituitary dependent hyperadrenocorticism in dogs
por: Nivy, Ran, et al.
Publicado: (2018)

Case report: Central-pituitary hypothyroidism concurrent with hyperadrenocorticism without pituitary macroadenoma in a Miniature Schnauzer dog
por: Chae, Yeon, et al.
Publicado: (2023)

Blood pressure‐lowering effects of sulodexide depend on albuminuria severity: post hoc analysis of the sulodexide microalbuminuria and macroalbuminuria studies
por: Olde Engberink, Rik H. G., et al.
Publicado: (2016)

Comparison of Survival Times for Dogs with Pituitary‐Dependent Hyperadrenocorticism in a Primary‐Care Hospital: Treated with Trilostane versus Untreated
por: Nagata, N., et al.
Publicado: (2016)

Long‐Term Survival of Dogs with Adrenal‐Dependent Hyperadrenocorticism: A Comparison between Mitotane and Twice Daily Trilostane Treatment
por: Arenas, C., et al.
Publicado: (2014)

An activating mutation in the CRHR1 gene is rarely associated with pituitary-dependent hyperadrenocorticism in poodles
por: De-Marco, Viviani, et al.
Publicado: (2017)

Diabetes mellitus remission in a cat with pituitary-dependent hyperadrenocorticism after trilostane treatment
por: Muschner, Adriana Cunha, et al.
Publicado: (2018)

Trismus due to myotonia associated with hyperadrenocorticism in a dog
por: YOKOTA, Shunya, et al.
Publicado: (2023)

Cortisol Concentrations in Well‐Regulated Dogs with Hyperadrenocorticism Treated with Trilostane
por: Midence, J.N., et al.
Publicado: (2015)

Quantitative CT assessment of bone mineral density in dogs with hyperadrenocorticism
por: Lee, Donghoon, et al.
Publicado: (2015)

Ultrasonographic evaluation of skin thickness in small breed dogs with hyperadrenocorticism
por: Heo, Seonghun, et al.
Publicado: (2018)

Successful treatment of occult hyperadrenocorticism with mitotane but not trilostane in a dog
por: Park, Su‐Min, et al.
Publicado: (2021)

Suspected spontaneous hyperadrenocorticism in a young experimental beagle dog
por: Obara, Ryo D., et al.
Publicado: (2021)

Evaluation of compounded trilostane packets for dogs with naturally occurring hyperadrenocorticism
por: Nam, Sookin, et al.
Publicado: (2021)

Antibody Response to Canine Parvovirus Vaccination in Dogs with Hyperadrenocorticism Treated with Trilostane
por: Bergmann, Michèle, et al.
Publicado: (2020)

Prevalence and risk factors associated with systemic hypertension in dogs with spontaneous hyperadrenocorticism
por: García San José, Paula, et al.
Publicado: (2020)

Erratum for “Evaluation of compounded trilostane packets for dogs with naturally occurring hyperadrenocorticism”
Publicado: (2022)

Canine Pancreatic‐Specific Lipase Concentrations in Clinically Healthy Dogs and Dogs with Naturally Occurring Hyperadrenocorticism
por: Mawby, D.I., et al.
Publicado: (2014)

Successful treatment of feline hyperadrenocorticism with pituitary macroadenoma using radiation therapy: a case study
por: YAYOSHI, Naoko, et al.
Publicado: (2022)

Overexpression of 11β-hydroxysteroid dehydrogenase 1 in visceral adipose tissue and underexpression of endothelial nitric oxide synthase in the adrenal cortex of dogs with hyperadrenocorticism
por: Miceli, Diego Daniel, et al.
Publicado: (2018)

Comparison of 2 Doses for ACTH Stimulation Testing in Dogs Suspected of or Treated for Hyperadrenocorticism
por: Aldridge, C., et al.
Publicado: (2016)

Metformin reduces insulin resistance and the tendency toward hyperglycaemia and dyslipidaemia in dogs with hyperadrenocorticism
por: Miceli, Diego Daniel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qjjmndohpqqiml20e7vqrc2amv